Chemicals & Advanced Materials Global On demand · 24-48h

Global Enteromorpha Compressa Extract Market Strategic Research Report

Global Enteromorpha Compressa Extract Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Enteromorpha Compressa Extract Market
$3532025
10.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Polysaccharide Content: <20%, Polysaccharide Content: 20%–50%, Polysaccharide Content: ≥50%–80%

By Application: Personal Care Products, Cosmetic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: ICHIMARU PHARCOS(JP), Presperse(US), Provital(ES), Ephyla(FR), GREENTECH(FR), Vantage(US), BIO-EXTRACTS(LK), Akott(IT), NUWEN(FR), MediSea Biotech(FR), Odycea(FR), ELICITYL(FR), Algaia(FR), Seaweed Solutions AS(NO), Sinochem Nanjing(CN), Baoji Oasier Bio-Tech(CN), Amazy Organic(CN), Hunan MT Health(CN), Xi'an Seven Herb Biotech(CN), Qingdao Seawin Biotech(CN), Parchem(US), MakingCosmetics(US), BioSynth(CH), Alidans(ES), BioMolenez(FR)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 147 pages
Market size 2025
$353
Million USD
Forecast CAGR
10.5%
2025-2032
Forecast 2032
$710.1
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Enteromorpha Compressa Extract market size is predicted to grow from US$ 353 million in 2025 to US$ 706 million in 2032; it is expected to grow at a CAGR of 10.5% from 2026 to 2032.

Ulva prolifera extract refers to a mixture of natural active ingredients obtained from marine green algae Ulva prolifera through processes such as water extraction, enzymatic hydrolysis, or supercritical fluid extraction. It is rich in polysaccharides (such as sulfated polysaccharides), amino acids, minerals, and polyphenols, and possesses moisturizing, antioxidant, soothing, and certain bioactive regulatory effects. It is widely used in functional skincare products, health foods, and marine biological resource development.

The Ulva prolifera extract industry chain mainly consists of upstream raw material acquisition (nearshore Ulva prolifera harvesting, cultivation, and preliminary drying), midstream extraction and processing (obtaining active ingredients such as sulfated polysaccharides through processes like water extraction, enzymatic hydrolysis, and membrane separation, followed by standardization), and downstream applications (functional skincare products, health foods, feed additives, and agricultural biostimulants, etc.). Upstream production is affected by seasonal outbreaks and resource distribution, resulting in lower added value and gross profit margins typically between 10% and 25%. Midstream extraction and processing, involving the enrichment and purification of active ingredients, possesses certain technological barriers, leading to gross profit margins generally between 30% and 60%. Downstream brands and formulations, leveraging functional claims and channel advantages, can achieve gross profit margins of 50% to 80%. Overall, the industry presents a typical marine biological extract industry structure of "resource-driven + technology-driven extraction value-added + terminal brand premium."

In 2025, the average price of Ulva prolifera extract was US$60 k/ton, with sales volume reaching 6,016 tons, and the total production capacity of Ulva prolifera extract in 2025 was 8,600 tons.

As an important branch of marine biological resource development, Ulva prolifera extract embodies a typical path of "high-value utilization of marine waste biological resources." Its core value lies in transforming seasonally occurring Ulva prolifera blooms along the coast (originally a burden on environmental governance) into functional raw materials rich in sulfated polysaccharides, amino acids, and minerals, showing potential applications in skincare, food, and agriculture. From an industry perspective, its advantages lie in the wide availability of raw materials, relatively low cost, and the "natural marine source" label, which helps align with the current trends of green sustainability and pure beauty. However, it also faces challenges such as insufficient stability of active ingredients, low standardization, and inadequate validation of high-end efficacy. Future development hinges on improving extraction and purification technologies, establishing a clear functional evaluation system, and extending into high-value-added applications (such as medical aesthetic raw materials and bioactive polysaccharides), thereby upgrading from a "resource-utilizing product" to a "functional high-end raw material."

Key Questions Addressed in this Report

What is the 10-year outlook for the global Enteromorpha Compressa Extract market?

What factors are driving Enteromorpha Compressa Extract market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Enteromorpha Compressa Extract market opportunities vary by end market size?

How does Enteromorpha Compressa Extract break out by Type, by Application?

This report presents a comprehensive overview of the global Enteromorpha Compressa Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Polysaccharide Content: <20%
  • Polysaccharide Content: 20%–50%
  • Polysaccharide Content: ≥50%–80%

Segment by Extraction Method

  • Water Extraction
  • Enzymatic Extraction
  • Microwave-Assisted Extraction

Segment by Grade

  • Agricultural Grade
  • Food Grade
  • Cosmetic Grade

Segment by Application

  • Personal Care Products
  • Cosmetic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Enteromorpha Compressa Extract market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Personal Care Products, Cosmetic, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Enteromorpha Compressa Extract Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$353
2025
Forecast
$710.1
2032
CAGR
10.5%
2025–2032
영역들
5
global
Key companies
ICHIMARU PHARCOS(JP)Presperse(US)Provital(ES)Ephyla(FR)GREENTECH(FR)Vantage(US)BIO-EXTRACTS(LK)Akott(IT)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Polysaccharide Content: <20%Polysaccharide Content: 20%–50%Polysaccharide Content: ≥50%–80%
By Application
Personal Care ProductsCosmeticOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Polysaccharide Content: <20%
  • 3.1.3 Polysaccharide Content: 20%–50%
  • 3.1.4 Polysaccharide Content: ≥50%–80%
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Personal Care Products
  • 4.1.3 Cosmetic
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 ICHIMARU PHARCOS(JP)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Presperse(US)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Provital(ES)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ephyla(FR)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 GREENTECH(FR)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Vantage(US)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 BIO-EXTRACTS(LK)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Akott(IT)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 NUWEN(FR)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 MediSea Biotech(FR)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Odycea(FR)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 ELICITYL(FR)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Algaia(FR)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Seaweed Solutions AS(NO)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Sinochem Nanjing(CN)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Baoji Oasier Bio-Tech(CN)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Amazy Organic(CN)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Hunan MT Health(CN)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Xi'an Seven Herb Biotech(CN)
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Qingdao Seawin Biotech(CN)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Parchem(US)
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 MakingCosmetics(US)
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 BioSynth(CH)
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Alidans(ES)
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 BioMolenez(FR)
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Enteromorpha Compressa Extract market?
The global Enteromorpha Compressa Extract market is estimated at US$ 353 million in 2025 (base year) and is projected to reach US$ 706 million by 2032.
What is the forecast CAGR for the Enteromorpha Compressa Extract market?
The market is expected to grow at a CAGR of 10.5% from 2026 to 2032, expanding from US$ 353 million in 2025 to US$ 706 million in 2032, roughly 2.0 times its base-year value.
What is Enteromorpha Compressa Extract?
Ulva prolifera extract refers to a mixture of natural active ingredients obtained from marine green algae Ulva prolifera through processes such as water extraction, enzymatic hydrolysis, or supercritical fluid extraction. It is rich in polysaccharides (such as sulfated polysaccharides), amino acids, minerals, and polyphenols, and possesses moisturizing, antioxidant, soothing, and certain bioactive regulatory effects. It is widely used in functional skincare products, health foods, and marine biological resource development.
How is the Enteromorpha Compressa Extract market segmented by type?
By type, the market is segmented into Polysaccharide Content: <20%, Polysaccharide Content: 20%–50% and Polysaccharide Content: ≥50%–80%.
What are the key applications of Enteromorpha Compressa Extract?
Key applications covered include Personal Care Products, Cosmetic and Other.
Which companies are profiled in the Enteromorpha Compressa Extract market report?
Key players profiled include ICHIMARU PHARCOS(JP), Presperse(US), Provital(ES), Ephyla(FR), GREENTECH(FR), Vantage(US), BIO-EXTRACTS(LK) and Akott(IT), among 25 companies covered in total.
What geographies does the Enteromorpha Compressa Extract market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Enteromorpha Compressa Extract?
Overall, the industry presents a typical marine biological extract industry structure of "resource-driven + technology-driven extraction value-added + terminal brand premium."
What are the main risks and barriers in the Enteromorpha Compressa Extract market?
Midstream extraction and processing, involving the enrichment and purification of active ingredients, possesses certain technological barriers, leading to gross profit margins generally between 30% and 60%.
Who should buy the Enteromorpha Compressa Extract market report?
The report is intended for manufacturers and solution providers, distributors and end users in Personal Care Products, Cosmetic and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Enteromorpha Compressa Extract market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.